Dose Response Trial of Pergolide for Cocaine Dependence - 1

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00000248
First received: September 20, 1999
Last updated: September 11, 2012
Last verified: May 1997
  Purpose
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Condition Intervention Phase
Cocaine-Related Disorders
Drug: Pergolide
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Dose Response Trial of Pergolide for Cocaine Dependence

Resource links provided by NLM:


Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Side effects
  • Drug use
  • Retention
  • Cocaine withdrawal
  • Compliance
  • Effectiveness of medication for global improvements

Estimated Enrollment: 0
Study Start Date: February 1996
  Eligibility

Ages Eligible for Study:   21 Years to 50 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000248

Locations
United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425 742
Sponsors and Collaborators
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Robert Malcolm, M.D. Medical University of South Carolina
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00000248     History of Changes
Other Study ID Numbers: NIDA-08355-1  R01DA008355  R01-08355-1 
Study First Received: September 20, 1999
Last Updated: September 11, 2012
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Cocaine
Pergolide
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Dopamine Agonists

ClinicalTrials.gov processed this record on July 24, 2016